885. Pregnancy Outcomes and Pharmacokinetics in Pregnant Women Living with HIV Exposed to Long-Acting Cabotegravir and Rilpivirine in Clinical Trials

BACKGROUND: Limited data exist among women living with HIV who become pregnant while exposed to long-acting (LA) cabotegravir (CAB) and rilpivirine (RPV). We report outcomes in pregnant participants and LA pharmacokinetic (PK) tail data in pregnant women exposed to CAB+RPV with live births. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Parul, Ford, Susan L, Baker, Mark, Meyer, Claudia, Garside, Louise, D’Amico, Ronald, Van Solingen-Ristea, Rodica, Crauwels, Herta, Polli, Joseph, Seal, Ciara, Thiagarajah, Shanker, Birmingham, Eileen, Spreen, William, Baugh, Bryan, Bosse, Matthew, Vannappagari, Vani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644735/
http://dx.doi.org/10.1093/ofid/ofab466.1080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644735/
http://dx.doi.org/10.1093/ofid/ofab466.1080

Ejemplares similares